American Shared Hospital Services

AMS Healthcare Medical Care Facilities

American Shared Hospital Services' revenue for fiscal 2025 (year ended December 2025) was $28.1 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 19.2%, EPS fell 75.0%, free cash flow grew 195.8% and total debt fell 32.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.

1.28 0.02 +1.59%
Market cap
$8.4M
P/E
0.0×
Fwd P/E
1.8×
Dividend yield
—
F-score
3/9
Altman Z
0.67
Beneish M
−2.06
Dividend safety
10/100

Insider Decisions trades per month

Total buys 1.34
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — 1 — — — —
Sell — — — — — — — — — — — —
Insider Ownership 35.83%

Capital & Financial Ratios $m

Market Cap 8.38
Revenue 30.41
Net Income (3.30)
Free Cash Flow 3.54
Net Debt 9.46
Current Ratio 0.77 (below 1: weak)
Debt/Equity 0.63
P/E ratio 0.00
Fwd P/E 1.80
P/S ratio 0.29
P/B ratio 0.34
Past 5Y EPS Growth —
This Y EPS Growth 39.13% (at or above 15%: strong)
Next Y EPS Growth (43.40%) (below 0%: weak)
Next Y revenue growth 55.16% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 0.18%
10-year low 10-year high
P/B against its own 10 years 3.06%
10-year low 10-year high
EV/Sales against its own 10 years 12.09%
10-year low 10-year high
EV/FCF against its own 10 years 96.55%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 14 11 4 7
Receivables 5 12 12 9
Inventory — — — —
Other — — — —
20 26 18 17
2023 2024 2025 Q'26
Payables 0 2 1 1
ST’ Debt 5 3 17 16
Other 3 4 4 3
11 10 23 22

Compound Annual Growth %

10y 5y 3y
Sales 5.43% 9.50% 12.46%
Cash Flow (9.65%) (20.48%) (24.63%)
Earnings 0.00% 0.00% 0.00%
Book Value 0.96% 3.21% 2.62%

Revenue $m

Mar Jun Sep Dec Year
’26 7 8 — — —
’25 6 7 7 8 28
’24 5 7 7 9 28
’23 5 6 5 6 21
’22 5 5 5 5 20
’21 4 4 4 5 18
’20 5 4 5 5 18
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 2 2 — — —
’25 3 0 2 (1) 3
’24 (2) 1 0 0 0
’23 2 3 4 (3) 6
’22 0 4 2 2 7
’21 3 1 (1) 3 6
’20 3 3 1 2 10
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 2 2 — — —
’25 (2) (2) (2) 1 (5)
’24 (3) 0 0 (4) (7)
’23 2 1 0 (3) (1)
’22 0 4 1 2 7
’21 2 2 (1) 2 5
’20 3 3 1 2 9
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.09) (0.07) — — —
’25 (0.10) (0.04) 0.00 (0.09) (0.23)
’24 0.02 0.55 (0.03) (0.20) 0.33
’23 0.03 (0.02) 0.02 0.06 0.10
’22 0.04 0.08 0.05 0.04 0.21
’21 0.00 (0.01) 0.01 0.04 0.03
’20 (0.02) (0.08) (0.03) (1.01) (1.14)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 1.51 2.45 2.19 2.30 1.16 2.03 2.08 2.16 2.37 2.01

Analyst estimates 2026–2028

Powerpack
High 3.50 5.00 3.95 3.30 3.58 5.04 3.10 3.75 4.60 3.26
People
People Employees 9 9 9 9 10 9 11 13 44 46
Revenue/emp, $m 2.08 2.17 2.19 2.29 1.78 1.96 1.80 1.64 0.64 0.61
Income, $m
Income, $m Revenue 19 20 20 21 18 18 20 21 28 28
Gross margin, % 47.03 44.30 37.97 33.58 25.04 38.16 42.45 43.82 32.41 18.03
EBT 3 2 2 2 (9) 1 3 1 1 (3)
EBT margin, % 17.07 9.39 10.56 7.56 (53.00) 5.37 12.75 3.26 4.36 (11.47)
Net income 2 3 2 1 (8) 1 2 0 2 (3)
Depreciation 6 7 7 7 7 5 5 5 6 6
Per share, $
Per share, $ Revenue 3.36 3.40 3.38 3.48 2.89 2.92 3.14 3.35 4.36 4.24
Earnings 0.17 0.33 0.18 0.11 (1.14) 0.03 0.21 0.10 0.34 (0.23)
Cash flow 1.50 1.36 1.38 1.36 1.58 1.04 1.15 0.90 0.03 0.47
Capex (0.19) (0.11) (0.27) (0.17) (0.05) (0.28) (0.06) (0.99) (1.18) (1.15)
Free cash flow 1.32 1.25 1.11 1.19 1.53 0.76 1.09 (0.09) (1.15) (0.69)
Book value 4.88 5.19 5.32 5.37 3.83 4.01 4.07 4.13 4.62 4.19
Shares, m 6 6 6 6 6 6 6 6 6 7
Valuation, ×
Valuation, × P/E 20.00 7.73 13.22 20.33 0.00 59.25 14.00 26.67 9.11 0.00
P/S 1.01 0.75 0.70 0.70 0.77 0.81 0.94 0.72 0.73 0.50
P/B 0.70 0.49 0.45 0.45 0.58 0.59 0.72 0.58 0.69 0.50
EV/Sales 2.03 1.56 0.89 0.82 0.95 1.24 0.99 0.80 1.05 1.29
EV/FCF 5.18 4.24 2.71 2.40 1.80 4.75 2.85 (30.77) (3.96) (7.97)
Cash, $m
Cash, $m Operating cash flow 8 8 8 8 10 6 7 6 0 3
Capex (1) (1) (2) (1) 0 (2) 0 (6) (8) (8)
Free cash flow 7 7 6 7 9 5 7 (1) (7) (5)
Balance, $m
Balance, $m Working capital (1) 0 0 3 (2) 9 14 10 16 (6)
Total debt 22 18 5 4 8 16 13 16 20 17
Net debt 19 16 4 3 3 8 1 2 9 14
Shareholders’ equity 27 30 31 32 24 24 26 26 30 28
Returns, %
Returns, % ROA 1.62 3.24 1.77 1.18 (14.49) 0.44 2.97 1.32 4.03 (2.69)
ROIC 4.44 3.30 3.35 2.81 (21.99) 2.66 5.70 0.60 (4.50) (5.43)
ROE 3.55 6.74 3.36 2.10 (25.45) 0.81 5.33 2.35 7.76 (5.38)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

American Shared Hospital Services vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CCEL Cryo-Cell International Inc. $29.4M — (loss-making) 43.8× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
DCGO DocGo Inc. $27.9M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR $15.9M — (loss-making) 8.3× +25,427.42% (above 0%: growing) n/m −206.36% (below 0%: shrinking) 42.70% (1.24%) Compare
CCM Concord Medical Services Holdings Limited $10.5M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
AMS American Shared Hospital Services $8.4M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%)
CANOQ Cano Health, Inc. $6.6M — (loss-making) — −21.05% (below 0%: shrinking) n/m −43.68% (below 0%: shrinking) 100.00% (16.23%) Compare
MODVQ ModivCare Inc. $6.2M — (loss-making) — (loss-making) −3.18% (below 0%: shrinking) n/m −3,767.70% (below 0%: shrinking) 14.06% (1.78%) Compare
BMGL Basel Medical Group Ltd $6.2M — — — — — — — Compare
RHEP Adcare Health Systems Inc $5.2M 0.6× — (loss-making) +143.03% (above 0%: growing) n/m +224.45% (above 0%: growing) 31.50% (0.88%) Compare
Median of peers $8.5M — — −0.02% — −132.28% 31.50% (1.24%)

All 55 Medical Care Facilities stocks →

American Shared Hospital Services (AMS) key facts

  • Concern: American Shared Hospital Services' revenue for fiscal 2025 (year ended December 2025) was $28.1 million, down 0.91% from fiscal 2024.
  • Concern: American Shared Hospital Services reported a net loss of $2.7 million, or a loss of $0.23 per share, for fiscal 2025.
  • American Shared Hospital Services (AMS) is a Medical Care Facilities company in the Healthcare sector, listed on NYSE American.
  • As of October 16, 2026, AMS traded at $1.28, a market capitalization of $8.4 million.
  • Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 0.3× sales.
  • Return on equity was −5.38% and debt-to-equity 0.63.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 0.67 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

American Shared Hospital Services (AMS) Latest News

7 Sep

Impact 1 ·
Impact 1 ·

4 Sep

Impact 1 ·
Impact 1 ·

3 Sep

Impact 1 ·

2 Sep

Impact 2 ·
Impact 1 ·

1 Sep

Impact 1 ·
Impact 1 ·
Impact 1 ·

28 Aug

Impact 1 ·

27 Aug

Impact 1 ·
Impact 1 ·

26 Aug

Impact 2 ·
Impact 1 ·
Impact 1 ·

25 Aug

Impact 2 ·
Impact 1 ·
Impact 1 ·

24 Aug

Impact 1 ·
Impact 1 ·
Impact 1 ·

20 Aug

Impact 3 · transcript
Impact 1 ·

19 Aug

Impact 1 ·
stockrow.com/AMS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com